Translational Development Acquisition Units (TDACU) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	213.66K	162.34K	281.16K	661.05K
Operating expense	213.66K	162.34K	281.16K	661.05K
Total operating expenses	213.66K	162.34K	281.16K	661.05K
Operating income	-213.66K	-162.34K	-281.16K	-661.05K
Other non operating income	-	-	-	-
EBT including unusual items	1.66M	1.60M	1.33M	946.98K
EBT excluding unusual items	1.66M	1.47M	1.33M	983.12K
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	1.66M	1.60M	1.33M	946.98K
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	1.87M	1.63M	1.61M	1.64M
Interest expense	-	-	-	-
Net interest expenses	1.87M	1.63M	1.61M	1.64M
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance